Concepedia

Karen Ling

KL

Statistics

Publications

35

Citations

2.7K

H-Index

27

Active since

2001

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of Southern California

Hong Kong University of Science and Technology

Harvard University

University of Hong Kong

Karen Ling is an author at Ionis Pharmaceuticals (United States) specializing in life sciences, neuroscience, and molecular neuroscience.

ORCID

Publications per year

2001–2025

35

Publications

35

<i>SMN2</i> splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

Nikolai A. Naryshkin, Marla Weetall, Amal Dakka et al. · Science · 2014 · 526 citations

, , +17

Mechanism of <i>STMN2</i> cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies

Michael W. Baughn, Ze’ev Melamed, Jone López‐Erauskin et al. · Science · 2023 · 247 citations · Full text

, , +17

Synaptic Defects in the Spinal and Neuromuscular Circuitry in a Mouse Model of Spinal Muscular Atrophy

Karen Ling, Ming-Yi Lin, Brian Zingg et al. · PLoS ONE · 2010 · 215 citations · Full text

, , +17

Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy

Karen Ling, Rebecca M. Gibbs, Z. Feng et al. · Human Molecular Genetics · 2011 · 203 citations · Full text

, , +17

Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System

Fernando J. Martínez, Gabriel A. Pratt, Eric L. Van Nostrand et al. · Neuron · 2016 · 192 citations · Full text

, , +15

1–5 of 35